Cite
HARVARD Citation
Parvizi, J. et al. (2022). Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?*. Journal of bone and joint surgery. pp. 2045-2046. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Parvizi, J. et al. (2022). Low-Molecular-Weight Heparin Is Superior to Aspirin in the Prevention of Thromboembolic Disease: Or Is It?*. Journal of bone and joint surgery. pp. 2045-2046. [Online].